SCHEMBL28644252

SCHEMBL28644252

Cc1ccc(-c2cc(Sc3cnc(CNC(=O)OC(C)(C)C)s3)cc(C(=O)OC(C)(C)C)c2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.41
LOXL2 Q9Y4K0 3/20 0.37
LOXL3 P58215 1/20 0.34
LIPC P11150 1/20 0.33
LIPG Q9Y5X9 1/20 0.33
CCNB2 O95067 1/20 0.33
CCNE2 O96020 1/20 0.33
CDK1 P06493 1/20 0.33
CDK4 P11802 1/20 0.33
CCNB1 P14635 1/20 0.33
CCND1 P24385 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
CCNB3 Q8WWL7 1/20 0.33
NAMPT P43490 1/20 0.33
DYRK1A Q13627 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
DGAT1 O75907 1/20 0.32
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29971072 1.00 PDPK1 (0.41) PDPK1LOXL2LOXL3LIPCLIPG
SCHEMBL20983568 0.93 LOXL2 (0.45) PDPK1LOXL2LOXL3CCNB2CCNE2
SCHEMBL19274665 0.91 PDPK1 (0.38) PDPK1LOXL2LOXL3DYRK1AL3MBTL1
SCHEMBL29971303 0.89 LOXL2 (0.45) PDPK1LOXL2LOXL3ACACBACACA
SCHEMBL28639514 0.84 GSK3B (0.40) PDPK1LOXL2LOXL3DYRK1A
SCHEMBL29971031 0.84 GSK3B (0.40) PDPK1LOXL2LOXL3DYRK1A
SCHEMBL22542983 0.83 PDPK1 (0.40) PDPK1CCNB2CCNE2CDK1CDK4
SCHEMBL29971469 0.83 PDPK1 (0.40) PDPK1CCNB2CCNE2CDK1CDK4
SCHEMBL29970963 0.83 PDPK1 (0.41) PDPK1LOXL2CCNB2CCNE2CDK1
SCHEMBL28644316 0.83 PDPK1 (0.41) PDPK1LOXL2CCNB2CCNE2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311839-B Methylamine derivatives as lysyl oxidase inhibitors for the treatment of cancer 癌症研究协会皇家癌症医院 2021-11-02 CN disclosed